Mycelex g
$ 17,00 – $ 39,00Price range: $ 17,00 through $ 39,00
Mysoline
$ 41,00 – $ 275,00Price range: $ 41,00 through $ 275,00
Mysimba
$ 70,00 – $ 688,00Price range: $ 70,00 through $ 688,00
Mysimba is an advanced oral medication specifically designed to support long-term weight management in adults. It features a unique combination of naltrexone and bupropion that works to regulate appetite and reduce food-related cravings. This treatment targets the reward system in the brain, making it easier to maintain portion control and resist snacking. For optimal results, it is used in conjunction with a balanced, reduced-calorie diet and regular physical activity. It provides a valuable option for individuals seeking to reach their weight goals and improve overall metabolic health.
Active substance: Bupropion, Naltrexone
SKU:
Mysimba
Category: Weight Loss
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Mysimba – What You Need to Know
Mysimba belongs to a combination class of central nervous system agents containing naltrexone hydrochloride and bupropion hydrochloride in an extended-release formulation. This fixed-dose combination targets neural pathways in the hypothalamus and mesolimbic dopamine circuit involved in food intake and reward processing.
The medication is dispensed in accordance with applicable federal and state regulations following a comprehensive evaluation by a qualified healthcare provider. It is designed to complement lifestyle modifications, including calorie-restricted nutrition and increased physical activity.
| Attribute | Details |
|---|---|
| Active ingredient | Naltrexone hydrochloride / Bupropion hydrochloride |
| Primary purpose | Chronic weight management |
| Dosage form | Extended-release tablet (8 mg / 90 mg) |
| Route of administration | Oral |
| Food intake | Take with meals; avoid high-fat meals |
| Storage | Store at controlled room temperature 20°C to 25°C (68°F to 77°F) |
How the drug works
The neurochemical mechanism relies on the synergistic actions of two distinct pharmacological agents: naltrexone, an opioid receptor antagonist, and bupropion, a weak dopamine and norepinephrine reuptake inhibitor. In the arcuate nucleus of the hypothalamus, bupropion stimulates pro-opiomelanocortin (POMC) neurons. This stimulation causes the release of alpha-melanocyte-stimulating hormone (alpha-MSH), which binds to melanocortin-4 receptors to signal satiety and decrease appetite. Concurrently, POMC activation triggers an endogenous opioid feedback loop via beta-endorphins, which normally inhibits further POMC cell firing. Naltrexone blocks this autoinhibitory feedback by binding to mu-opioid receptors, thereby allowing sustained neuronal firing of POMC cells and prolonged suppression of food cravings within the central nervous system.
What it’s used for
This formulation is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients. Clinical criteria for initiation include an initial Body Mass Index (BMI) of 30 kg/m² or greater (classified as obese), or a BMI of 27 kg/m² to less than 30 kg/m² (overweight) in the presence of at least one weight-related comorbid condition. Such comorbidities include controlled hypertension, dyslipidemia, or type 2 diabetes mellitus. Evaluation of treatment efficacy is typically conducted after 16 weeks of full-dose therapy to assess whether adequate weight reduction has occurred to justify ongoing administration.
Dosing schedule
Therapy initiates with a mandatory four-week dose-escalation schedule designed to minimize gastrointestinal discomfort and facilitate physiological adaptation. During Week 1, the standard dose is one tablet (8 mg naltrexone HCl / 90 mg bupropion HCl) taken orally once daily in the morning. Week 2 increases the regimen to one tablet in the morning and one tablet in the evening. Week 3 requires two tablets in the morning and one tablet in the evening. At Week 4, the full maintenance dosage is reached: two tablets twice daily (totaling 32 mg naltrexone HCl and 360 mg bupropion HCl per day). Tablets must be swallowed whole with fluid and must not be crushed, split, or chewed.
How it’s absorbed and eliminated
Following oral administration, peak plasma concentrations (Cmax) of bupropion occur approximately 3 hours after dosing, whereas naltrexone reaches Cmax within approximately 2 hours. Co-administration with high-fat meals significantly increases systemic exposure: bupropion exposure (AUC) increases by 35% and peak concentration increases by 80%, while naltrexone exposure increases by 105% and peak concentration increases by 270%. Bupropion undergoes extensive hepatic metabolism via the CYP2B6 isoenzyme into active metabolites, notably hydroxybupropion. Naltrexone is metabolized primarily by dihydrodiol dehydrogenase to 6-beta-naltrexol. The elimination half-life of bupropion is approximately 21 hours, whereas 6-beta-naltrexol exhibits a half-life of roughly 13 hours. Excretion occurs primarily through renal pathways.
Compatibility with other medicines
Simultaneous administration with monoamine oxidase inhibitors (MAOIs) is strictly contraindicated due to the risk of severe hypertensive reactions; a minimum of 14 days must elapse between discontinuing an MAOI and initiating therapy. Because bupropion is a potent inhibitor of the CYP2D6 metabolic pathway, caution is required when co-prescribing drugs cleared by this enzyme, including certain antidepressants, antipsychotics, and beta-blockers. Concomitant use of opioid-containing medications, such as analgesic opioids or cough suppressants, is contraindicated because naltrexone blocks opioid receptors, negating efficacy and potentially precipitating acute opioid withdrawal. Patients using medications that lower the seizure threshold require careful risk assessment prior to therapy.
Adverse reactions
The most frequently reported adverse effects in clinical trials involve the gastrointestinal system, with nausea occurring in a high percentage of patients, particularly during initial dose titration. Additional common reactions include constipation, vomiting, dry mouth, headache, insomnia, dizziness, and hot flushes. Cardiovascular reactions include transient or persistent elevations in resting blood pressure and resting heart rate. Less frequent but clinically significant adverse events include anxiety, tremor, tinnitus, hyperhidrosis, and altered taste perception. Patients experiencing hypersensitivity manifestations, such as urticaria or angioedema, require immediate medical intervention.
Important precautions
Bupropion carries warnings regarding neuropsychiatric risks, including potential changes in mood, psychosis, hallucinations, paranoia, and suicidal ideation, particularly in adolescents and young adults. The medication is contraindicated in individuals with a current seizure disorder or a prior history of seizures. It is also contraindicated in patients with a current or prior diagnosis of bulimia or anorexia nervosa, due to a higher frequency of seizures observed in this population during bupropion therapy. Abrupt withdrawal from alcohol, benzodiazepines, barbiturates, or antiepileptic drugs during treatment is dangerous and prohibited. Pre-existing hypertension must be adequately controlled before starting treatment and monitored regularly throughout therapy.
What to avoid while taking it
Alcohol intake should be minimized or completely avoided during treatment. Excessive consumption of alcohol or sudden cessation of regular alcohol use while taking bupropion-containing medications increases the susceptibility to generalized tonic-clonic seizures. Additionally, ingestion of high-fat meals alongside tablet administration should be avoided due to the significant increase in drug absorption and peak plasma levels, which heighten the probability of experiencing severe adverse reactions such as nausea or neurological side effects.
If you skip a dose
If a dose is missed at the scheduled time, the patient should skip that specific tablet and resume the standard administration routine at the next planned interval. Administering extra tablets or doubling the dose to compensate for a missed administration is strictly contraindicated. Taking a higher dose than prescribed elevates systemic plasma levels of bupropion above recommended thresholds, which substantially increases the risk of triggering a seizure.
Practical tips
Tablets should be ingested whole with water during or shortly after a light to moderate meal. Breaking, dividing, or crushing extended-release tablets destroys the specialized release matrix, releasing active compounds rapidly and increasing the risk of adverse reactions. Maintaining a consistent daily schedule with approximately 12 hours between morning and evening doses optimizes therapeutic drug levels in blood plasma while minimizing peak-related adverse events.
Special populations
Safety and effectiveness have not been established in pediatric patients under 18 years of age; use in this age group is not recommended. In elderly patients, decreased renal function may impair drug elimination; baseline renal assessment and clinical monitoring are indicated. The medication is contraindicated during pregnancy, as weight loss offers no benefit to a pregnant woman and may cause fetal harm. Nursing mothers should avoid use, as both active ingredients and their metabolic products are excreted into human breast milk.
Common questions
What should be done if blood pressure increases during treatment?
Blood pressure and pulse rate should be measured prior to starting therapy and monitored at regular intervals during treatment. If a patient experiences a clinically significant, persistent increase in blood pressure or heart rate, dosage reduction or discontinuation of the medication must be considered under medical supervision.
How does this medication interact with surgical procedures requiring anesthesia?
If elective surgery requiring opioid analgesia is planned, therapy should be temporarily suspended prior to the procedure. Because naltrexone blocks opioid receptors, higher doses of opioid analgesics would be needed to overcome the block, which increases the risk of severe respiratory depression and circulatory collapse.
Is it safe to drive or operate heavy machinery while taking this medication?
Central nervous system effects such as dizziness, somnolence, and impaired concentration may occur during dose titration. Patients should evaluate their individual physiological response to the medication before engaging in hazardous tasks such as driving a vehicle or operating machinery.
Why is gradual dose titration necessary during the first four weeks?
The four-week dose escalation schedule allows the central nervous system and gastrointestinal tract to adapt to the active substances. Stepwise increases help reduce the incidence and severity of common early side effects, notably nausea and vomiting, while gradually building toward the full therapeutic maintenance dose.
What action is required if weight loss targets are not met after 16 weeks?
If a patient has not lost at least 5% of their initial body weight after 16 weeks of treatment (including four weeks on the full maintenance dose), healthcare providers typically re-evaluate the treatment plan. Discontinuation is generally recommended if this threshold is not achieved, as the probability of achieving meaningful long-term weight reduction thereafter is low.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
90mg+8mg |
|---|---|
| Package |
10 tabs ,20 tabs ,30 tabs ,60 tabs ,90 tabs ,120 tabs ,180 tabs ,270 tabs ,360 tabs |
| Ενεργός Ουσία | , |
Related products
Alli
$ 41,00 – $ 317,00Price range: $ 41,00 through $ 317,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Hoodia
$ 80,00 – $ 294,00Price range: $ 80,00 through $ 294,00
Active substance: oxypregnane steroidal glycoside
More Details
This product has multiple variants. The options may be chosen on the product page
Obelit
$ 33,00 – $ 474,00Price range: $ 33,00 through $ 474,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Orligal
$ 13,00 – $ 42,00Price range: $ 13,00 through $ 42,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Rybelsus
$ 250,00 – $ 880,00Price range: $ 250,00 through $ 880,00
Active substance: Semaglutide
More Details
This product has multiple variants. The options may be chosen on the product page
Slimfast
$ 20,00 – $ 54,00Price range: $ 20,00 through $ 54,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Trim Z
$ 50,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Vyfat
$ 40,00 – $ 105,00Price range: $ 40,00 through $ 105,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
